Trial Details
TERMINATEDBasic Information
| Clinical ID | c1419 |
|---|---|
| Identifier | NCT00279435 |
| Trial Title | Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab Study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: visilizumab |
Participant Information
| Sponsor | Facet Biotech |
|---|---|
| City | Atlanta |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2|PHASE3 |
Time Information
| Start Date | 2025-08-06 |
|---|---|
| Primary Completion Date | 2025-08-07 |
| Completion Date | 2025-08-07 |